US2023211048A1PendingUtilityA1
Biologic breast implant
Est. expiryMay 30, 2039(~12.8 yrs left)· nominal 20-yr term from priority
C12N 5/0653A61F 2/12A61L 27/56A61L 27/3604A61L 27/3691A61L 27/3633A61L 2430/04A61L 2430/40A61F 2230/0004A61F 2240/004A61L 27/3641A61L 27/3687
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides tissue products produced from adipose tissues, as well as methods for producing such tissue products. The tissue products can include acellular tissue matrices for treatment of a breast.
Claims
exact text as granted — not AI-modified1 . A tissue product, comprising:
a breast implant, the implant comprising a construct of acellular adipose tissue matrix including particulate acellular adipose tissue matrix that has been formed into a suspension, dried, and stabilized to form a porous acellular tissue matrix sponge, wherein the suspension comprises 2-10% by weight solid content.
2 . The tissue product of claim 1 , wherein the implant is in the form of a rounded breast implant.
3 . The tissue product of claim 1 , wherein the implant is in the form of a tear-drop shaped breast implant.
4 . The tissue product of claim 1 , wherein the suspension comprises 2-5% by weight solid content.
5 . The tissue product of claim 4 , wherein the suspension comprises 2-4% by weight solid content
6 . The tissue product of claim 1 , wherein the sponge comprises a desired thickness at least in the thickest part of the sponge, the desired thickness exceeding 10.0 cm.
7 . The tissue product of claim 1 , wherein the implant is stabilized by cross-linking.
8 . A tissue product, comprising:
a breast implant, the implant comprising a construct of acellular adipose tissue matrix including particulate acellular adipose tissue matrix that has been formed into a suspension, dried, and stabilized to form a porous acellular tissue matrix sponge having a porosity produced based on a solid content of the suspension prior to drying.
9 . The tissue product of claim 8 , wherein the implant is in the form of a rounded breast implant.
10 . The tissue product of claim 8 , wherein the implant is in the form of a tear-drop shaped breast implant.
11 . The tissue product of claim 8 , wherein the sponge comprises a desired thickness at least in the thickest part of the sponge, the desired thickness exceeding 10.0 cm.
12 . The tissue product of claim 8 , wherein the implant is stabilized by cross-linking.
13 . The tissue product of claim 1 , wherein the suspension comprises 2-5% by weight solid content.
14 . The tissue product of claim 1 , wherein the suspension comprises 2-4% by weight solid content.
15 . A method for producing a tissue product, comprising the steps of:
selecting an adipose tissue; treating the tissue to remove substantially all cellular material from the tissue; suspending the tissue in a liquid to form a suspension with a 2-10% by weight solid content; and freezing and drying the suspension to form a porous sponge.
16 . The method of claim 15 , further comprising cross-linking the porous sponge.
17 . The method of claim 16 , wherein cross-linking is performed using a dehydrothermal process.
18 . The method of claim 17 , further comprising performing a chemical cross-linking step.
19 . The method of claim 15 , wherein the porous sponge comprises a desired thickness at least in the thickest part of the sponge, the desired thickness exceeding 10.0 cm.
20 . The method of claim 15 , further comprising adding the suspension to a mold.
21 . The method of claim 20 , wherein the mold is in the shape of a round or a tear-drop breast implant.
22 . The method of claim 18 , wherein the chemical cross-linking step includes at least one of glutaraldehyde, genipin, carbodiimides, and diisocyanates.
23 . The method of claim 18 , wherein cross-linking includes heating the porous sponge.
24 . The method of claim 23 , wherein the porous sponge is heated in a vacuum.
25 . The method of claim 24 , wherein the porous sponge is heated to a range of 70° C. to 120° C.
26 . The method of claim 18 , wherein the porous sponge is cross-linked such that the material maintains a stable three-dimensional structure when contacted with an aqueous environment.
27 . The method of claim 26 , wherein the aqueous environment is a mammalian body.
28 . The method of claim 15 , wherein the suspension comprises 2-5% by weight solid content.
29 . The method of claim 15 , wherein the suspension comprises 2-4% by weight solid content.Join the waitlist — get patent alerts
Track US2023211048A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.